Home Monitoring for Thoracic Surgery Patients
Atrial Fibrillation
About this trial
This is an interventional supportive care trial for Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria:
- Patient willing to provide informed consent
- Availability of a caregiver at the patient's home
- Wi-fi or cellular connectivity at the patient's home
- Undergoing elective segmentectomy, lobectomy, or pneumonectomy; VATS or open procedure and any thoracic foregut procedure like esophagectomy etc
- ASA III or lower
- Ability to comprehend and consent in English
- Patient or caregiver familiar/comfortable with the use of the technology like online banking
Exclusion Criteria:
- Unstable disease process preoperatively
- Patient requiring postoperative ICU admission
- Expected unstable disease process in the postoperative period
Sites / Locations
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Control Group
Home Monitoring Group
The control group will not be monitored with continuity of care. After this period, 30-day emergency department visits will be measured and compared between the two groups, along with 30-day readmission rates, in-hospital length of stay, mortality, quality of recovery 40 item scale (QoR-40), European Quality of Life 5 Dimensions (EQ5D), patient satisfaction score, and societal and hospital cost. No intervention will be administered.
At the time of hospital discharge, the control group will be discharged without receipt of home monitoring, and the intervention group will receive a home monitoring kit with (NIBP (non-invasive blood pressure) and SPO2 (pulse oximetry) with instructions on how to use these devices. Patients in the intervention groups will receive digital communication for four weeks and have their NIBP, HR (heart rate), SPO2 and pain scores evaluated twice a day for two weeks.